Bio-Techne

TECH Health Care Market cap $11.3B as of Sep 14, 2026 16:00 ET S&P 500

Q4 FY26 Apr 1 – Jun 30, 2026 reported Aug 24, 2026

Revenue$0.32B +1% year over year

Gross profit$0.21B 66% margin

Operating profit$0.07B 23% margin

Net profit$0.06B 17% margin

The numbers behind the diagram

All figures in billions of U.S. dollars, for Q4 FY26 (period ends Jun 30, 2026).
Item	Value	Share of revenue	Year over year
Revenue	0.32	100%	+1%
Protein sciences	0.23	70%
Diagnostics	0.09	27%
Other revenue	0.01	3%
Cost of revenue	−0.11	34%
Gross profit	0.21	66% margin	+3pp
SG&A	−0.11	35%	−27pp
Other	−0.02	8%	+0pp
Operating profit	0.07	23% margin	+31pp
Interest & other costs	−<0.01
Tax	−0.02
Net profit	0.06	17% margin	+23pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q3 FY26 (period ends Mar 31, 2026).
Item	Value	Share of revenue	Year over year
Revenue	0.31	100%	−2%
Consumables	0.26	83%	+0%
Instruments	0.03	9%	+6%
Services	0.02	7%	−21%
Royalty	0.01	1%	−1%
Cost of revenue	−0.10	33%
Gross profit	0.21	67% margin	−1pp
SG&A	−0.11	35%	−13pp
Other	−0.02	8%	+0pp
Operating profit	0.08	24% margin	+12pp
Interest & other costs	−<0.01
Tax	−0.02
Net profit	0.05	16% margin	+9pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Dec 31, 2025).
Item	Value	Share of revenue	Year over year
Revenue	0.30	100%	+0%
Consumables	0.24	79%	+2%
Instruments	0.03	10%	−4%
Services	0.02	8%	−18%
Royalty	0.01	3%	+5%
Cost of revenue	−0.11	35%
Gross profit	0.19	65% margin	−1pp
SG&A	−0.11	38%	−2pp
Other	−0.02	8%	+0pp
Operating profit	0.05	18% margin	+2pp
Interest & other costs	−<0.01
Tax	−0.01
Net profit	0.04	13% margin	+1pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Sep 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	0.29	100%	−1%
Consumables	0.23	81%	+0%
Services	0.03	9%	+0%
Instruments	0.02	8%	−17%
Royalty	0.01	2%	+12%
Cost of revenue	−0.10	34%
Gross profit	0.19	66% margin	+2pp
SG&A	−0.12	41%	−1pp
Other	−0.02	8%	+0pp
Operating profit	0.05	17% margin	+3pp
Tax	−0.01
Net profit	0.04	13% margin	+2pp

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Mar 31, 2025).
Item	Value	Share of revenue	Year over year
Revenue	0.32	100%	+4%
Consumables	0.26	82%	+4%
Services	0.03	8%	+7%
Instruments	0.03	8%	−1%
Royalty	0.01	2%	+7%
Cost of revenue	−0.10	32%
Gross profit	0.22	68% margin	+0pp
SG&A	−0.15	48%	+11pp
Other	−0.03	8%	+0pp
Operating profit	0.04	12% margin	−10pp
Tax	−0.02
Net profit	0.02	7% margin	−9pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

Financial health

The balance sheet, the quarter's capital flow, the debt schedule and the capital structure of the quarter shown above.

Every set of results we hold, newest first. Open one on its own page.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q4 FY26 Apr 1 – Jun 30, 2026 reported Aug 24, 2026 Operating margin 23% Net profit $0.06B	Apr 1 – Jun 30, 2026	Aug 24, 2026	$0.32B	+1%	23%	$0.06B	17%
Q3 FY26 Jan 1 – Mar 31, 2026 reported May 6, 2026 Operating margin 24% Net profit $0.05B	Jan 1 – Mar 31, 2026	May 6, 2026	$0.31B	−2%	24%	$0.05B	16%
Q2 FY26 Oct 1 – Dec 31, 2025 reported Feb 4, 2026 Operating margin 18% Net profit $0.04B	Oct 1 – Dec 31, 2025	Feb 4, 2026	$0.30B	+0%	18%	$0.04B	13%
Q1 FY26 Jul 1 – Sep 30, 2025 reported Nov 5, 2025 Operating margin 17% Net profit $0.04B	Jul 1 – Sep 30, 2025	Nov 5, 2025	$0.29B	−1%	17%	$0.04B	13%
Q3 FY25 Jan 1 – Mar 31, 2025 reported May 8, 2025 Operating margin 12% Net profit $0.02B	Jan 1 – Mar 31, 2025	May 8, 2025	$0.32B	+4%	12%	$0.02B	7%